This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.


One shot to stop Group B Streptococcus

This fact sheet describes PATH’s work to develop a vaccine against Group B Streptococcus. It details current prevention methods, global disease burden, and the maternal immunization strategy. It also describes PATH’s vaccine development partnership with the Biovac Institute in Cape Town, South Africa.

Publication date: August 2018

One shot to stop Group B Streptococcus

191 KB PDF

View Resource